Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity
Yi-Cheng Chang, Meng-Lun Hsieh, Hsiao-Lin Lee, Siow-Wey Hee, Chi-Fon Chang, Hsin-Yung Yen, Yi-An Chen, Yet-Ran Chen, Ya-Wen Chou, Fu-An Li, Yi-Yu Ke, Shih-Yi Chen, Ming-Shiu Hung, Alfur Fu-Hsin Hung, Jing-Yong Huang, Chu-Hsuan Chiu, Shih-Yao Lin, Sheue-Fang Shih, Chih-Neng Hsu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMetabolism, Diabetes, and Cancer · Cancer, Lipids, and Metabolism
Correction to: EMBO Molecular Medicine. 10.1038/s44321-025-00216-4 | Published online 21 March 2025
In this article the affiliation details for Teng-Kuang Yeh were incorrectly given as “AltruBio Taiwan R&D Center, Taipei 114063, Taiwan” but should have been “Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan”. The original article has been corrected.
In this article the e-mail address of the corresponding author Lun Kelvin Tsou was incorrect. The original article has been corrected.